Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female aci rats induced by estrogen

Hormones and Cancer

Volumn 1, Issue 1, 2010, Pages 34-43

  Weroha, S John ^a,b,c   Lingle, Wilma L ^c   Hong, Yan ^a,b   Li, Sara Antonia ^a,b   Li, Jonathan J ^a,b  

^a UNIVERSITY OF KANSAS CANCER CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Aci rat; Breast cancer; Cyclin E1 CDK2; Estrogen

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E; ESTRADIOL; MESSENGER RNA; PHOSPHOTRANSFERASE; PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST; BREAST CELL; BREAST HYPERPLASIA; BREAST TUMOR; CANCER INVASION; CELL CYCLE; CENTROSOME; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE AMPLIFICATION; IMMUNOPRECIPITATION; IN VITRO STUDY; INTRADUCTAL CARCINOMA; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, WESTERN; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CELL TRANSFORMATION, NEOPLASTIC; CENTROSOME; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; ESTROGENS; FEMALE; IMMUNOPRECIPITATION; MAMMARY NEOPLASMS, EXPERIMENTAL; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED ACI; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 78650202724     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-009-0004-z     Document Type: Article

References (45)

1. The American Cancer Society (2008) Cancer facts & figures 2008. The American Cancer Society, New York
2. Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Anderson WF, Szeszenia-Dabrowska N, Bardin-Mikolajczak A et al (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 16:439-443
3. Surveillance, Epidemiology, and End Results (SEER) Oncogene. 2008 Feb 21; 27(9):1253-1262. Program (www.seercancer.gov) SEER*Stat, Database: Incidence- SEER17 Reqs Limited-Use, Nov. 2006 Sub (2000-2004) Linked to County, Attributes- Total US 1969-2004 Counties, National Cancer Institute, DCCPS, Surveillance, Research Program, Cancer Statistics Branch, released April 2007. Based on the November 2006 submission
4. Alberts SR, Ingle JN, Roche PR, Cha SS, Wold LE, Farr GH Jr, Krook JE, Wieand HS (1996) Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials. Cancer 78:764-772
5. Li CI, Daling JR, Malone KE (2003) Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 21:28-34
6. Arnerlov C, Emdin SO, Cajander S, Bengtsson NO, Tavelin B, Roos G (2001) Intratumoral variations in DNA ploidy and s-phase fraction in human breast cancer. Anal Cell Pathol 23:21-28
7. Wiesener B, Hauser-Kronberger CE, Zipperer E, Dietze O, Menzel C, Hacker GW (1998). p34cdc2 in invasive breast cancer: relationship to DNA content, Ki67 index and c-erbB-2 expression. Histopathology 33:522-530
8. Katayama H, Brinkley WR, Sen S (2003) The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev 22:451-464
9. Marumoto T, Zhang D, Saya H (2005) Aurora-A-a guardian of poles. Nat Rev Cancer 5:42-50
10. Li JJ, Li SA (2006) Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis. Pharmacol Ther 111:974-984
11. Tanaka T, Kimura M, Matsunaga K, Fukada D, Mori H, Okano Y (1999) Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res 59:2041-2044
12. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL (2002) Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA 99:1978-1983
13. Perez-Roger I, Solomon DL, Sewing A, Land H (1997) Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene 14:2373-2381
14. Butt AJ, Caldon CE, McNeil CM, Swarbrick A, Musgrove EA, Sutherland RL (2008) Cell cycle machinery: links with genesis and treatment of breast cancer. Adv Exp Med Biol 630:189-205
15. Fukasawa K (2008) P53, cyclin-dependent kinase and abnormal amplification of centrosomes. Biochim Biophys Acta 1786:15-23
16. Hinchcliffe EH, Li C, Thompson EA, Maller JL, Sluder G (1999) Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283:851-854
17. Matsumoto Y, Hayashi K, Nishida E (1999) Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr Biol 9:429-432
18. Ferguson RL, Maller JL (2008) Cyclin E-dependent localization of MCM5 regulates centrosome duplication. J Cell Sci 121:3224-3232
19. Duensing A, Liu Y, Perdreau SA, Kleylein-Sohn J, Nigg EA, Duensing S (2007) Centriole overduplication through the concurrent formation of multiple daughter centrioles at single maternal templates. Oncogene 26:6280-6288
20. Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE et al (2000) Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103:127-140
21. Chen Z, Indjeian VB, McManus M, Wang L, Dynlacht BD (2002) CP110, a cell cycle-dependent CDK substrate, regulates centro-some duplication in human cells. Dev Cell 3:339-350
22. Fisk HA, Winey M (2001) The mouse Mps1p-like kinase regulates centrosome duplication. Cell 106:95-104
23. Nishimura T, Takahashi M, Kim HS, Mukai H, Ono Y (2005) Centrosome-targeting region of CG-NAP causes centrosome amplification by recruiting cyclin E-cdk2 complex. Genes Cells 10:75-86
24. Basto R, Brunk K, Vinadogrova T, Peel N, Franz A, Khodjakov A, Raff JW (2008) Centrosome amplification can initiate tumorigenesis in flies. Cell 133:1032-1042
25. Li JJ, Papa D, Davis MF, Weroha SJ, Aldaz CM, El-Bayoumy K, Ballenger J, Tawfik O, Li SA (2002) Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer. Mol Carcinog 33:56-65
26. Li JJ, Weroha SJ, Lingle WL, Papa D, Salisbury JL, Li SA (2004) Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proc Natl Acad Sci USA 101:18123-18128
27. Li JJ, Li SA (2007) Deciphering the conundrum of estrogendriven breast cancer: Aurora kinase deregulation. In: Melmed SRH, Chanson P, Christen Y (eds) Hormonal control of cell cycle. Springer, Heidelberg, pp 49-62
28. Baker GL, Landis MW, Hinds PW (2005) Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation. Cell Cycle 4:330-338
29. Nelsen CJ, Kuriyama R, Hirsch B, Negron VC, Lingle WL, Goggin MM, Stanley MW, Albrecht JH (2005) Short term cyclin D1 overexpression induces centrosome amplification, mitotic spindle abnormalities, and aneuploidy. J Biol Chem 280:768-776
30. Page DL, Dupont WD (1990) Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66:1326-1335
31. Spruck C, Sun D, Fiegl H, Marth C, Mueller-Holzner E, Goebel G, Widschwendter M, Reed SI (2006) Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer. Cancer Res 66:7355-7360
32. Akli S, Zheng PJ, Multani AS, Wingate HF, Pathak S, Zhang N, Tucker SL, Chang S, Keyomarsi K (2004) Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res 64:3198-3208
33. Bodin L, Beaune PH, Loriot MA (2005) Determination of cytochrome P450 2D6 (CYP2D6) gene copy number by real- time quantitative PCR. J Biomed Biotechnol 3:248-253
34. Weroha SJ, Li SA, Tawfik O, Li JJ (2006) Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis 27:491-498
35. 172H mutant and p53- knockout mice after chemical carcinogenesis: evidence for a gain of function. Mol Carcinogenesis 23:185-192
36. Neben K, Tews B, Wrobel G, Hahn M, Kokocinski F, Giesecke C, Krause U, Ho AD, Kramer A, Lichter P (2004) Gene expression patterns in acute myeloid leukemia correlate with centrosome aberrations and numerical chromosome changes. Oncogene 23:2379-2384
37. Russell A, Thompson MA, Hendley J, Trute L, Armes J, Germain D (1999) Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer. Oncogene 18:1983- 1991
38. Bartkova J, Zemanova M, Bartek J (1996) Abundance and subcellular localisation of cyclin D3 in human tumours. Int J Cancer 65:323-327
39. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54:380-385
40. Scott KA, Walker RA (1997) Lack of cyclin E immunoreactivity in non-malignant breast and association with proliferation in breast cancer. Br J Cancer 76:1288-1292
41. Keyomarsi K, Pardee AB (1993) Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci U S A 90:1112-1116
42. Enders GH (2002) Cyclins in breast cancer: too much of a good thing. Breast Cancer Res 4:145-147
43. Courjal F, Louason G, Speiser P, Katsaros D, Zeillinger R, Theillet C (1996) Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int J Cancer 69:247-253
44. Schraml P, Bucher C, Bissig H, Nocito A, Haas P, Wilber K, Seelig S, Kononen J, Mihatsch MJ, Dirnhofer S et al (2003) Cyclin E overexpression and amplification in human tumours. J Pathol 200:375-382
45. Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI (2001) Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413:316-322